AU1580395A - Microgranules of 5-nitro imidazole derivatives - Google Patents
Microgranules of 5-nitro imidazole derivativesInfo
- Publication number
- AU1580395A AU1580395A AU15803/95A AU1580395A AU1580395A AU 1580395 A AU1580395 A AU 1580395A AU 15803/95 A AU15803/95 A AU 15803/95A AU 1580395 A AU1580395 A AU 1580395A AU 1580395 A AU1580395 A AU 1580395A
- Authority
- AU
- Australia
- Prior art keywords
- microgranules
- imidazole derivatives
- medicinal
- nitro imidazole
- hand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9400394A FR2715067B1 (en) | 1994-01-14 | 1994-01-14 | New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract. |
FR94/00394 | 1994-01-14 | ||
PCT/FR1995/000039 WO1995019168A1 (en) | 1994-01-14 | 1995-01-12 | Microgranules of 5-nitro imidazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1580395A true AU1580395A (en) | 1995-08-01 |
AU705570B2 AU705570B2 (en) | 1999-05-27 |
Family
ID=9459066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15803/95A Ceased AU705570B2 (en) | 1994-01-14 | 1995-01-12 | Microgranules of 5-nitro imidazole derivatives |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPH09507499A (en) |
KR (1) | KR100320140B1 (en) |
CN (1) | CN1088357C (en) |
AT (1) | ATE187068T1 (en) |
AU (1) | AU705570B2 (en) |
BR (1) | BR9506507A (en) |
CZ (1) | CZ286080B6 (en) |
DE (1) | DE69513632T2 (en) |
DK (1) | DK0739201T3 (en) |
ES (1) | ES2139883T3 (en) |
MA (1) | MA23429A1 (en) |
MX (1) | MX9602772A (en) |
NZ (1) | NZ279238A (en) |
OA (1) | OA10583A (en) |
PL (1) | PL178424B1 (en) |
PT (1) | PT739201E (en) |
RU (1) | RU2152212C1 (en) |
SK (1) | SK282066B6 (en) |
UA (1) | UA28031C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10849884B2 (en) | 2014-09-05 | 2020-12-01 | Lupin Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4331930B2 (en) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | High content granules of acid labile drugs |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
DE3822095A1 (en) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF |
DE69131574T2 (en) * | 1990-05-14 | 2000-05-04 | Gary R. Jernberg | SURGICAL IMPLANT AND METHOD FOR EMBEDDING CHEMOTHERAPEUTICS |
-
1995
- 1995-01-12 PL PL95315530A patent/PL178424B1/en not_active IP Right Cessation
- 1995-01-12 AU AU15803/95A patent/AU705570B2/en not_active Ceased
- 1995-01-12 NZ NZ279238A patent/NZ279238A/en unknown
- 1995-01-12 CN CN95191222A patent/CN1088357C/en not_active Expired - Fee Related
- 1995-01-12 BR BR9506507A patent/BR9506507A/en not_active IP Right Cessation
- 1995-01-12 CZ CZ19962055A patent/CZ286080B6/en not_active IP Right Cessation
- 1995-01-12 PT PT95907683T patent/PT739201E/en unknown
- 1995-01-12 RU RU96117257/14A patent/RU2152212C1/en not_active IP Right Cessation
- 1995-01-12 MX MX9602772A patent/MX9602772A/en not_active IP Right Cessation
- 1995-01-12 UA UA96083232A patent/UA28031C2/en unknown
- 1995-01-12 JP JP7518878A patent/JPH09507499A/en active Pending
- 1995-01-12 ES ES95907683T patent/ES2139883T3/en not_active Expired - Lifetime
- 1995-01-12 DK DK95907683T patent/DK0739201T3/en active
- 1995-01-12 SK SK914-96A patent/SK282066B6/en unknown
- 1995-01-12 DE DE69513632T patent/DE69513632T2/en not_active Expired - Fee Related
- 1995-01-12 KR KR1019960703797A patent/KR100320140B1/en not_active IP Right Cessation
- 1995-01-12 AT AT95907683T patent/ATE187068T1/en not_active IP Right Cessation
- 1995-01-13 MA MA23756A patent/MA23429A1/en unknown
-
1996
- 1996-07-12 OA OA60863A patent/OA10583A/en unknown
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10849884B2 (en) | 2014-09-05 | 2020-12-01 | Lupin Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
US10857133B2 (en) | 2014-09-05 | 2020-12-08 | Lupin Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
US11000508B2 (en) | 2014-09-05 | 2021-05-11 | Lupin Inc. | Secnidazole for use in the treatment of trichomoniasis |
US11000507B2 (en) | 2014-09-05 | 2021-05-11 | Lupin Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
US11020377B2 (en) | 2014-09-05 | 2021-06-01 | Lupin Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
US11324721B2 (en) | 2014-09-05 | 2022-05-10 | Lupin Inc. | Secnidazole for use in the treatment of trichomoniasis |
US11602522B2 (en) | 2014-09-05 | 2023-03-14 | Lupin Inc. | Secnidazole for use in the treatment of sexually transmitted infection |
US11684607B2 (en) | 2014-09-05 | 2023-06-27 | Lupin, Inc. | Secnidazole for use in the treatment of bacterial vaginosis |
Also Published As
Publication number | Publication date |
---|---|
ES2139883T3 (en) | 2000-02-16 |
MX9602772A (en) | 1997-05-31 |
CZ205596A3 (en) | 1996-10-16 |
KR100320140B1 (en) | 2002-07-02 |
BR9506507A (en) | 1997-09-09 |
CN1088357C (en) | 2002-07-31 |
DE69513632T2 (en) | 2000-04-06 |
NZ279238A (en) | 1998-03-25 |
JPH09507499A (en) | 1997-07-29 |
OA10583A (en) | 2002-07-10 |
SK282066B6 (en) | 2001-10-08 |
RU2152212C1 (en) | 2000-07-10 |
SK91496A3 (en) | 1996-12-04 |
PL315530A1 (en) | 1996-11-12 |
PT739201E (en) | 2000-05-31 |
DE69513632D1 (en) | 2000-01-05 |
AU705570B2 (en) | 1999-05-27 |
MA23429A1 (en) | 1995-10-01 |
DK0739201T3 (en) | 2000-05-01 |
UA28031C2 (en) | 2000-10-16 |
CN1138826A (en) | 1996-12-25 |
ATE187068T1 (en) | 1999-12-15 |
PL178424B1 (en) | 2000-04-28 |
CZ286080B6 (en) | 2000-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2216437A1 (en) | Pharmaceutical composition containing selected lanthanum carbonate hydrates | |
EP2261200A3 (en) | Modified forms of pharmacacologically active agents and uses therefor | |
AU763094C (en) | Benzimidazoles, production thereof and use thereof as medicaments | |
AU3119195A (en) | Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy | |
WO2000012112A3 (en) | Treatment of lesions with xanthine oxidoreductase | |
AU1392900A (en) | 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses | |
USD412224S (en) | Portable pet ramp | |
EP1003526A4 (en) | Covalently linked n,o-carboxymethylchitosan and uses thereof | |
AU7459600A (en) | Smooth muscle cell promoter and uses thereof | |
AU8918998A (en) | Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection | |
USD395140S (en) | Furcal lampholder support for use on track | |
AU2091100A (en) | The optical quantum medical technology and the instrument thereof | |
AU2841801A (en) | Triazolotriazinones and the use thereof | |
WO2003045429A3 (en) | Anti-t cell immunotoxin fusion protein and its therapeutic use | |
WO1998053850A3 (en) | Compositions and means for the treatment of burns and other cutaneous traumas | |
AU2011501A (en) | Benzimidazoles, production thereof and the use thereof as antithrombotic | |
AU4789099A (en) | Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents | |
WO1999021574A3 (en) | Enhancement of morphogen activity | |
AU1580395A (en) | Microgranules of 5-nitro imidazole derivatives | |
AU3853097A (en) | Benzimidazole derivatives, preparation thereof, and therapeutical uses thereof | |
WO1999020259A3 (en) | Compositions containing thiamphenicol and diclofenac | |
HK1045514A1 (en) | Optically pure camptothecin analogues and composition and use thereof. | |
USD428446S (en) | Game apparatus | |
WO1999064065A3 (en) | Tumour therapy and imaging | |
WO2000017366A3 (en) | Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |